C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2004
12/29/2004	EP1490350A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
12/29/2004	EP1490349A1 Therapeutic ion channel blocking agents and methods of use thereof
12/29/2004	EP1490344A2 Anxiolytic agents with reduced sedative and ataxic effects
12/29/2004	EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators
12/29/2004	EP1490341A1 Novel adamantane derivatives
12/29/2004	EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
12/29/2004	EP1334094B1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
12/29/2004	EP1282612B1 Alkynyl phenyl heteroaromatic glucokinase activators
12/29/2004	EP1233769A4 Novel compounds
12/29/2004	EP1230224B1 Substituted 5-benzyl-2,4-diaminopyrimidines
12/29/2004	EP1226136B1 Tyrosine kinase inhibitors
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase
12/29/2004	EP0929545B1 Tricyclic inhibitors of farnesyl protein transferase
12/29/2004	CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004	CN1558898A Antiviral agent
12/29/2004	CN1558897A Antidiabetic agents
12/29/2004	CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1557808A 3-substituted piperazine triadimenol antifungal compounds and their salts
12/29/2004	CN1182135C Method for producing heterocyclic compounds
12/29/2004	CN1182123C Substituted bicyclic derivatives useful as anticancer agents
12/29/2004	CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	CA2526103A1 Cannabinoid derivatives, methods of making, and use thereof
12/29/2004	CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/28/2004	US6835845 Methine compound, material for organic luminescence element, and organic luminescence element using the same
12/28/2004	US6835741 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835732 Modulation of the adenosine A2A receptor; cardioprotective agents; antiischemic agents; antihypoxia agents; central nervous system disorders, Alzheimer's disease, Parkinson's disease, anxiolytic agents; antidepressants; analgesics
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835725 Cyanine dye containing heterocylic rings; satisfies light stability, favorable signal/noise rato, damage free application to the substrate material, use in the information layer in a write-once optical data carrier
12/28/2004	US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/28/2004	US6835474 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
12/23/2004	WO2004111046A2 Thiazoles as inhibitors of the alk- 5 receptor
12/23/2004	WO2004111043A1 Zwitterionic non-linear optophores and devices incorporating same
12/23/2004	WO2004111040A1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
12/23/2004	WO2004111032A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111022A1 3-(1,1-DIOXOTETRAHYDRO-1,2-THIAZIN-2-YL) or 3-(1,1-DOXO-ISOTHIAZOLIDIN-2YL) SUBSTITUTED BENZAMIDE COMPOUNDS AS ASP2 INHIBITORS
12/23/2004	WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
12/23/2004	WO2004111013A1 Hepatitis c virus inhibitors
12/23/2004	WO2004111010A1 Isoquinoline -1,3,4-trione, the synthetic method and the use thereof
12/23/2004	WO2004110999A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
12/23/2004	WO2004110993A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	WO2004110452A1 2-aminopyrimidine derivatives as raf kinase inhibitors
12/23/2004	WO2004110436A1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/23/2004	WO2004110418A2 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
12/23/2004	WO2004110350A2 Compouds and uses thereof in modulating amyloid beta
12/23/2004	WO2004110344A2 New azetidine compounds
12/23/2004	WO2004091518A3 Cxcr4 chemokine receptor binding compounds
12/23/2004	WO2004089908A3 3-azabicyclo[3.2.1]octane derivatives
12/23/2004	WO2004087048A3 Benzamide modulators of metabotropic glutamate receptors
12/23/2004	WO2004078128A3 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/23/2004	WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
12/23/2004	WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments
12/23/2004	WO2004071447A3 Substituted azole derivatives as therapeutic agents
12/23/2004	WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators
12/23/2004	WO2003093250A3 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/23/2004	US20040260098 Synthesis of epothilones, intermediates thereto and analogues thereof
12/23/2004	US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259924 A metabolite of repinotan hydrochloride that have high affinity for binding to the serotonin receptors of the 5-HT1A type; treating stroke or skull-brain trauma; anxiolytic agents; antidepressants; sexual, sleep and food disorders
12/23/2004	US20040259923 Compound useful as cellular adhesion protein and as antiedemic agent
12/23/2004	US20040259921 EP4 receptor selective agonists in the treatment of osteoporosis
12/23/2004	US20040259914 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula
12/23/2004	US20040259910 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
12/23/2004	US20040259904 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example
12/23/2004	US20040259894 inhibitors of cyclin-dependent kinases (CDKs); cancer, leukemia, psoriasis
12/23/2004	US20040259887 Cannabinoid receptor ligands and uses thereof
12/23/2004	US20040259884 Antiproliferative agents; antitumor agents; using 1-(4,5-bis(4-chlorophenyl)-2-(2,4-dimethoxyphenyl)-4,5-imidazol-1-yl)-2-methylpropan-1-one
12/23/2004	US20040259873 For treating, preventing and managing various disease or disorders such as central nervous system (CNS) disorders; myelodysplastic syndrome (MDS) and related syndromes; complex regional pain syndrome (CRPS) and related syndromes; cancer
12/23/2004	US20040259870 Antidiabetic agents; obesity; controlling appetite
12/23/2004	US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/23/2004	US20040259868 Serine protease inhibitors
12/23/2004	US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259859 Therapy for diseases caused by opioid receptors; irratible bowel disorders; drug abuse; antidepressants; anxiolytic agents; schizophrenia; eating disorders
12/23/2004	US20040259843 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
12/23/2004	US20040259031 Specific dye compound, optical information recording medium comprising specific dye, and information recording method using this optical information recording medium
12/23/2004	DE10308354A1 Cycloalkylderivate mit biosteren Carbonsäure-Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Cycloalkyl biosteren with carboxylic acid groups, method for their preparation and their use as medicaments
12/23/2004	CA2529090A1 2-aminopyrimidine derivatives as raf kinase inhibitors
12/23/2004	CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	CA2528321A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
12/23/2004	CA2528003A1 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
12/23/2004	CA2527851A1 Hepatitis c virus inhibitors
12/23/2004	CA2526770A1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/23/2004	CA2525207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487829A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
12/22/2004	EP1487828A2 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487798A1 Substituted tetrahydroisoquinolines as c5a receptor modulators

1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 628